P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM
Sky (Low-Risk) is a relatively harmless condition. The biggest risk for Sky is overtreatment. Within Sky, the most favorable subtype of all (Low-Sky) is defined by all the usual Sky criteria of Gleason 3+3=6, PSA less than 10 and minimal or no palpable disease on DRE. In addition, to qualify as Low-Sky, the PSA density must be less than 0.15, there can be no more than two biopsy cores containing cancer and no single core can be more than 50 percent involved. Men in Low-Sky have the best chance for staying on surveillance long term without requiring treatment. At the other end of the spectrum (within Sky) is High-Sky which is defined by all the usual Sky criteria but with one or more of the following: palpable disease, a PSA density over 0.15 or more than 50% of the biopsy cores containing cancer. These men are at somewhat greater risk for disease progression, i.e., the eventual need to go off active surveillance and undergo treatment. Basic-Sky falls between the Low and High subtypes. As would be expected, the risk for men with Basic-Sky to require future treatment is intermediate between Low and High.
Various testosterone inactivating pharmaceuticals (TIP) are used to treat prostate cancer. This post addresses Casodex (Bicalutamide) as a stand-alone therapy with the goal of reducing side effects commonly associated with …
Listen: https://soundcloud.com/prostate-oncology/six-not-a-bad-score “There’s rapid progress ongoing in the prostate cancer world and new treatments are being developed all the time. One of the major advantages of active surveillance is postponing …
BY MARK SCHOLZ,MD A Cancer that Can be Watched If someone tells you your cancer can be watched instead of treated, your initial reaction might be that they have no …
BY MARK SCHOLZ, MD What Is the Best Therapy for Me? This is one of the greatest questions for men with prostate cancer. How do you arrive at a reliable …
BY MARK SCHOLZ, MD Unhealthy diets encourage prostate cancer’s growth and spread. Consider Asia, where mortality from prostate cancer is eighteen times lower than in the United States. Genetic factors …
When I was 10 years old, my mother lost a close friend to cancer. I was too young to know anything about serious illness, but when I asked her why …
(These FAQs are for men who have received an elevated PSA or have a definitive diagnosis of prostate cancer. As medical oncologists who specialize in the treatment of prostate cancer …
BY MARK SCHOLZ, MD For prostate cancer patients, an optimal treatment plan is the most important factor for long-term survival, and finding that ideal treatment begins with accurate staging. The …
BY MARK SCHOLZ, MD Being diagnosed with cancer often stimulates people into action and triggers powerful survival instincts. Numerous purveyors of alternative medicine cater to these natural fears, and in …
BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …